Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil
Natalia Fintelman‐Rodrigues(Fundação Oswaldo Cruz), Thiago Moreno L. Souza(National Institute of Science and Technology), Carolina Q. Sacramento(National Institute of Science and Technology), Felipe Saraiva, Aline de Paula Dias da Silva(Fundação Oswaldo Cruz), Carlos Morel(Lackland Independent School District), Monique Cristina dos Santos(Fundação Oswaldo Cruz), André M. Vale(Universidade Federal do Rio de Janeiro), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Isaclaudia G. de Azevedo(Universidade Federal do Rio de Janeiro), João Silveira Moledo Gesto(Fundação Oswaldo Cruz), Marcelo Alves Ferreira, Fernando A. Bozza(D’Or Institute for Research and Education), Hongdong Tan(BGI Group (China)), Diogo Tschoeke(Universidade Federal do Rio de Janeiro), Vinícius Cardoso Soares(Universidade Federal do Rio de Janeiro), Danielle A.S. Rodrigues(Universidade Federal do Rio de Janeiro), Hui Jiang(State Key Laboratory of Digital Medical Engineering)
Cited by 26
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Lipid droplets: platforms with multiple functions in cancer hallmarks
|Cell Death and Disease|2020|530
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527